谷歌浏览器插件
订阅小程序
在清言上使用

Neoadjuvant Chemotherapy (Nct) Response In Postmenopausal Women With Clinical Stage Ii Or Iii Estrogen Receptor Positive (Er+) And Her2 Negative (Her2-) Breast Cancer (Bc) Resistant To Endocrine Therapy (Et) In The Alternate Trial (Alliance A011106)

CANCER RESEARCH(2021)

引用 0|浏览20
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要